Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Myricetin.
Myricetin is a polyhydroxyl flavonol that modulates glucose metabolism and provides neuroprotection through the inhibition of oxidative stress and the regulation of SIRT1 and PI3K/Akt signaling pathways.
5281672
318.23 g/mol
1.2
3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Myricetin across standard consumer modalities.
Low aqueous solubility and poor intestinal permeability necessitate the use of micronized particles or lipid-based carriers to ensure consistent bioavailability.
The high phenolic content can lead to oxidative degradation and undesirable browning reactions when exposed to the heat and moisture of pectin-based processing.
Limited payload capacity of thin films restricts the inclusion of effective therapeutic doses, typically requiring high-potency extracts or complexation with cyclodextrins.
Ready to launch a product featuring Myricetin? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Myricetin extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Myricetin payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation